Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Spratlin

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Current Oncology Reports|January 12, 2011
Ramucirumab (IMC-1121B): Monoclonal antibody inhibition of vascular endothelial growth factor receptor-2Jennifer Spratlin
Critical Reviews in Oncology/Hematology|November 10, 2006
Pharmacogenetics of paclitaxel metabolismJennifer Spratlin, Michael B Sawyer
The Oncologist|August 22, 2014
How prognostic and predictive biomarkers are transforming our understanding and management of advanced gastric cancerChristina Kim, Karen Mulder, Jennifer Spratlin
Medical Oncology (Northwood, London, England)|February 3, 2021
Real-world patterns of adjuvant chemotherapy treatment for patients with resected pancreatic adenocarcinomaOmar Abdel-Rahman, Jennifer Spratlin, Sheryl Koski
Journal of Cancer Research and Clinical Oncology|April 1, 2020
Vitamin and herbal supplements' use among patients with advanced gastrointestinal cancers included in eight clinical trialsOmar Abdel-Rahman, Jennifer Spratlin, Sheryl Koski
Expert Opinion on Biological Therapy|February 2, 2011
The role of bevacizumab in colorectal cancer: understanding its benefits and limitationsKaren Mulder, Andrew Scarfe, Neil Chua, et al.
Cryobiology|May 26, 2004
Beneficial effects of supplemental buffer and substrate on energy metabolism during small bowel storagePayam Salehi, Jennifer Spratlin, Tze-Feng Chong, et al.
Oncotarget|February 15, 2011
Antiangiogenic agents in advanced gastrointestinal malignancies: past, present and a novel futureKaren Mulder, Sheryl Koski, Andrew Scarfe, et al.
JCO Oncology Practice|February 2, 2022
Changing Rates of Goals of Care Designations in Patients With Advanced Pancreatic Cancer During a Multifactorial Advanced Care Planning Initiative: A Real-World Evidence StudyMatthew Anaka, Minji Lee, Elisa Lim, et al.
BMC Bioinformatics|March 29, 2024
Feature-specific quantile normalization and feature-specific mean-variance normalization deliver robust bi-directional classification and feature selection performance between microarray and RNAseq dataDaniel Skubleny, Sunita Ghosh, Jennifer Spratlin, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Current Oncology Reports|January 12, 2011
Ramucirumab (IMC-1121B): Monoclonal antibody inhibition of vascular endothelial growth factor receptor-2Jennifer Spratlin
Critical Reviews in Oncology/Hematology|November 10, 2006
Pharmacogenetics of paclitaxel metabolismJennifer Spratlin, Michael B Sawyer
The Oncologist|August 22, 2014
How prognostic and predictive biomarkers are transforming our understanding and management of advanced gastric cancerChristina Kim, Karen Mulder, Jennifer Spratlin
Medical Oncology (Northwood, London, England)|February 3, 2021
Real-world patterns of adjuvant chemotherapy treatment for patients with resected pancreatic adenocarcinomaOmar Abdel-Rahman, Jennifer Spratlin, Sheryl Koski
Journal of Cancer Research and Clinical Oncology|April 1, 2020
Vitamin and herbal supplements' use among patients with advanced gastrointestinal cancers included in eight clinical trialsOmar Abdel-Rahman, Jennifer Spratlin, Sheryl Koski
Expert Opinion on Biological Therapy|February 2, 2011
The role of bevacizumab in colorectal cancer: understanding its benefits and limitationsKaren Mulder, Andrew Scarfe, Neil Chua, et al.
Cryobiology|May 26, 2004
Beneficial effects of supplemental buffer and substrate on energy metabolism during small bowel storagePayam Salehi, Jennifer Spratlin, Tze-Feng Chong, et al.
Oncotarget|February 15, 2011
Antiangiogenic agents in advanced gastrointestinal malignancies: past, present and a novel futureKaren Mulder, Sheryl Koski, Andrew Scarfe, et al.
JCO Oncology Practice|February 2, 2022
Changing Rates of Goals of Care Designations in Patients With Advanced Pancreatic Cancer During a Multifactorial Advanced Care Planning Initiative: A Real-World Evidence StudyMatthew Anaka, Minji Lee, Elisa Lim, et al.
BMC Bioinformatics|March 29, 2024
Feature-specific quantile normalization and feature-specific mean-variance normalization deliver robust bi-directional classification and feature selection performance between microarray and RNAseq dataDaniel Skubleny, Sunita Ghosh, Jennifer Spratlin, et al.
Pageof 3